Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.93B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.72B |
| 3 |
Microsoft
MSFT
|
+$1.23B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.04B |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$891M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.73B |
| 2 |
Apple
AAPL
|
+$1.64B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.55B |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$639M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$595M |
Sector Composition
| 1 | Technology | 20.41% |
| 2 | Financials | 10.04% |
| 3 | Consumer Discretionary | 9.06% |
| 4 | Healthcare | 8.84% |
| 5 | Industrials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Sapiens International
SPNS
$2.4B
| $4.57M | ﹤0.01% |
157,912
-33,613
| -18% | -$973K |
|
2627
Virtu Financial
VIRT
$3.11B
| $4.56M | ﹤0.01% |
225,202
+64,620
| +40% | +$1.31M |
|
2628
Ligand Pharmaceuticals
LGND
$3.18B
| $4.56M | ﹤0.01% |
63,876
-5,965
| -9% | -$426K |
|
2629
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.15B
| $4.55M | ﹤0.01% |
64,283
+28,685
| +81% | +$2.03M |
|
2630
Sutro Biopharma
STRO
$75.5M
| $4.55M | ﹤0.01% |
1,060,582
-30,809
| -3% | -$132K |
|
2631
Credo Technology Group
CRDO
$28.5B
| $4.55M | ﹤0.01% |
233,665
+59,873
| +34% | +$1.17M |
|
2632
American Public Education
APEI
$639M
| $4.55M | ﹤0.01% |
471,346
+4,225
| +0.9% | +$40.8K |
|
2633
John Wiley & Sons Class A
WLY
$2.19B
| $4.55M | ﹤0.01% |
143,229
-620,431
| -81% | -$19.7M |
|
2634
HUB Group
HUBG
$2.25B
| $4.54M | ﹤0.01% |
197,516
-232,072
| -54% | -$5.33M |
|
2635
National Beverage
FIZZ
$3.61B
| $4.53M | ﹤0.01% |
91,191
-22,149
| -20% | -$1.1M |
|
2636
Hovnanian Enterprises
HOV
$869M
| $4.51M | ﹤0.01% |
28,972
-6,328
| -18% | -$985K |
|
|
LGF.B
2637
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $4.51M | ﹤0.01% |
442,375
+47,735
| +12% | +$486K |
|
2638
Treace Medical Concepts
TMCI
$461M
| $4.51M | ﹤0.01% |
353,522
+231,471
| +190% | +$2.95M |
|
2639
Alignment Healthcare
ALHC
$3.24B
| $4.5M | ﹤0.01% |
522,198
-360,545
| -41% | -$3.1M |
|
2640
MaxLinear
MXL
$1.42B
| $4.49M | ﹤0.01% |
189,043
-137,909
| -42% | -$3.28M |
|
|
DCBO
2641
Docebo
DCBO
$869M
| $4.48M | ﹤0.01% |
+92,615
| New | +$4.48M |
|
2642
Jamf
JAMF
$1.39B
| $4.45M | ﹤0.01% |
246,509
+124,607
| +102% | +$2.25M |
|
|
ZUO
2643
DELISTED
Zuora, Inc.
ZUO
| $4.45M | ﹤0.01% |
473,298
+209,066
| +79% | +$1.97M |
|
2644
Tango Therapeutics
TNGX
$737M
| $4.45M | ﹤0.01% |
449,215
+334,355
| +291% | +$3.31M |
|
2645
Invesco FTSE RAFI US 1000 ETF
PRF
$8.21B
| $4.44M | ﹤0.01% |
+126,228
| New | +$4.44M |
|
|
OPI
2646
Office Properties Income Trust
OPI
$52.8M
| $4.44M | ﹤0.01% |
606,171
-32,198
| -5% | -$236K |
|
2647
Zentalis Pharmaceuticals
ZNTL
$103M
| $4.44M | ﹤0.01% |
292,881
+69,620
| +31% | +$1.05M |
|
2648
Maxeon Solar Technologies
MAXN
$67.9M
| $4.44M | ﹤0.01% |
6,186
+2,106
| +52% | +$1.51M |
|
2649
Miller Industries
MLR
$459M
| $4.43M | ﹤0.01% |
104,748
-17,367
| -14% | -$734K |
|
2650
Olema Pharmaceuticals
OLMA
$527M
| $4.43M | ﹤0.01% |
315,478
+221,543
| +236% | +$3.11M |
|